#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteosarcoma recurrent Retinitis pigmentosa Loeys-Dietz syndrome Small cell lung cancer limited stage Univentricular heart Oesophageal adenocarcinoma stage II Neuromyelitis optica spectrum disorder Haemophilia A with anti factor VIII Alexander disease Fms-like tyrosine kinase 3 positive Immunodeficiency common variable Hyperchylomicronaemia Stiff person syndrome CDKL5 deficiency disorder Glioma More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Trials in Disease Medulloblastoma recurrent – Basic Information Pemphigoid – Trials in Disease Krabbe’s disease – Treatment Proteus syndrome – Life with Disease Arterial tortuosity syndrome Synovial sarcoma recurrent – Basic Information Factor VIII deficiency Cholangitis sclerosing – Trials in Disease Idiopathic inflammatory myopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Interferon Beta-1A AP31969 SULFATE Glepaglutide Phenylephrine Hydrochloride Pilocarpine Nitrate Granisetron Travoprost Dipyridamole CEFTAROLINE FOSAMIL Sodium Iodide (123 I) Cefixime Trihydrate Ivospemin Tiotropium Bromide Monohydrate Mogamulizumab Mr0005 SAR444336 Amlitelimab Phenylephrine Tinzaparin Vx-670 More therapies…

    Learn about Your Condition

    Haemorrhagic stroke Barrett's oesophagus Prodromal Alzheimer's disease Vertebrobasilar stroke Diabetic autonomic neuropathy Knee arthroplasty Tendon rupture Still's disease Hairy cell leukaemia recurrent Vascular malformation Atrial flutter Reperfusion injury Rhabdoid tumour Spermatocele Mitral valve disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Regorafenib with Chemotherapy for Newly Diagnosed Patients with Metastatic Ewing Sarcoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma metastatic
    • Ewing’s sarcoma
    Investigated Drugs:
    • Regorafenib
    Denmark France Italy The Netherlands Spain

  • Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral amyloid angiopathy
    Investigated Drugs:
    • Acetylcysteine Amide
    Iceland

  • Study on Gene Therapy with AAVrh10 for Infants with Krabbe Disease Undergoing Stem Cell Transplantation

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Krabbe’s disease
    Investigated Drugs:
    • Adeno-Associated Virus Serotype Rh10 Containing The Human Galc Gene
    Spain

  • Safety Study of Afamelanotide for Patients with Early Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Afamelanotide
    Italy

  • Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Trisomy 21
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin
    • Cytarabine
    Austria Belgium Czechia Germany Italy The Netherlands +1

  • Study on the Effects of Plitidepsin for Adults with Long COVID Symptoms

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Dexchlorpheniramine
    • Plitidepsin
    • Dexamethasone Phosphate
    Spain
Previous Page
1 … 897 898 899 900 901 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!